Mindpeak News | First Deep Learning AI in Clinical Routine in US!

January 7, 2022

First Deep Learning AI in Clinical Routine in US!

The first deep learning AI software for digital pathology that actually made it into clinical routine in a US laboratory (as LDT) comes from Mindpeak GmbH, a German AI company! Thanks BioReference Laboratories for your trust! And the deep integration of the AI software into the digital workflow platform (IMS) was a key element for jointly achieving this milestone. Thanks Gestalt Diagnostics, LLC for the great collaboration! Please check out the press release.

You may also be interested in

August 19, 2025

Mindpeak Expands to the United States with New Headquarters in Boston

Find out more about our AI-based diagnostics

Mindpeak is committed to protecting and respecting your privacy. We use your personal data solely for managing your account and providing the products and services you have requested from us. From time to time, we would like to inform you about our products and services, as well as other content that may be of interest to you. If you agree to be contacted for this purpose, please indicate below how you would like us to reach you:

I agree to receive other communications from mindpeak.

You can unsubscribe from these notifications at any time. For more information on how to unsubscribe, our privacy practices, and how we protect and respect your privacy, please refer to our Privacy Policy.

By clicking “Submit” below, you consent to Mindpeak storing and processing the personal data you have provided above in order to deliver the requested content to you.Indem Sie unten auf „Einsenden“ klicken, stimmen Sie zu, dass Mindpeak die oben angegebenen persönlichen Daten speichert und verarbeitet, um Ihnen die angeforderten Inhalte bereitzustellen.
‍

Thank you!
Your submission has been received.

Oops! Something went wrong while submitting the form.